We may be confronting a perfect storm driven by three primary forces: destructive effects of the Inflation Reduction Act (IRA), legal/regulatory battles over copay adjustment programs, and uncertainties following a national election.

As we approach 2025, it’s crucial for manufacturers to take proactive steps to ensure resilient and responsive patient support programs.

Tune in as we examine the key forces likely to impact patient support programs (PSPs) in the coming year, including the steps manufacturers can take to ride out the storm and offer powerful programs despite these challenges.

In this session, we’ll cover:

  1. Assessing your brand portfolio for specific risks
  2. Leveraging your government affairs for legislative insights
  3. Building strong partnerships with patient advocacy groups

Don’t miss this opportunity to equip yourself with the knowledge and strategies to thrive in a changing landscape. Secure your spot today and be ready to lead in patient support!

 

Watch it now (or any time)

Featuring a conversation with:

Chris Dowd
SVP, Market Development, ConnectiveRx
Jon McHenry
Vice President,
North Star Opinion Research
KevinH-1
Health Policy Manager,
HIV + Hepatitis Policy Institute